Subconjunctival Drug Administration

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 228 Experts worldwide ranked by ideXlab platform

Arto Urtti - One of the best experts on this subject based on the ideXlab platform.

  • Barrier analysis of periocular Drug delivery to the posterior segment.
    Journal of Controlled Release, 2010
    Co-Authors: Veli-pekka Ranta, Eliisa Mannermaa, Kirsi Lummepuro, Astrid Subrizi, Antti Laukkanen, Maxim Antopolsky, Lasse Murtomäki, Margit Hornof, Arto Urtti
    Abstract:

    Periocular Administration is a potential way of delivering Drugs to their targets in posterior eye segment (vitreous, neural retina, retinal pigment epithelium (RPE), choroid). Purpose of this study was to evaluate the role of the barriers in periocular Drug delivery. Permeation of FITC-dextrans and oligonucleotides in the bovine sclera was assessed with and without Pluronic gel in the donor compartment. Computational model for Subconjunctival Drug delivery to the choroid and neural retina/vitreous was built based on clearance concept. Kinetic parameters for small hydrophilic and lipophilic Drug molecules, and a macromolecule were obtained from published ex vivo and in vivo animal experiments. High negative charge field of oligonucleotides slows down their permeation in the sclera. Pluronic does not provide adequate rate control to modify posterior segment Drug delivery. Theoretical calculations for Subconjunctival Drug Administration indicated that local clearance by the blood flow and lymphatics removes most of the Drug dose which is in accordance with experimental results. Calculations suggested that choroidal blood flow removes most of the Drug that has reached the choroid, but this requires experimental verification. Calculations at steady state using the same subconconjunctival input rate showed that the choroidal and vitreal concentrations of the macromolecule is 2-3 orders of magnitude higher than that of small molecules. The evaluation of the roles of the barriers augments to design new Drug delivery strategies for posterior segment of the eye.

Veli-pekka Ranta - One of the best experts on this subject based on the ideXlab platform.

  • Barrier analysis of periocular Drug delivery to the posterior segment.
    Journal of Controlled Release, 2010
    Co-Authors: Veli-pekka Ranta, Eliisa Mannermaa, Kirsi Lummepuro, Astrid Subrizi, Antti Laukkanen, Maxim Antopolsky, Lasse Murtomäki, Margit Hornof, Arto Urtti
    Abstract:

    Periocular Administration is a potential way of delivering Drugs to their targets in posterior eye segment (vitreous, neural retina, retinal pigment epithelium (RPE), choroid). Purpose of this study was to evaluate the role of the barriers in periocular Drug delivery. Permeation of FITC-dextrans and oligonucleotides in the bovine sclera was assessed with and without Pluronic gel in the donor compartment. Computational model for Subconjunctival Drug delivery to the choroid and neural retina/vitreous was built based on clearance concept. Kinetic parameters for small hydrophilic and lipophilic Drug molecules, and a macromolecule were obtained from published ex vivo and in vivo animal experiments. High negative charge field of oligonucleotides slows down their permeation in the sclera. Pluronic does not provide adequate rate control to modify posterior segment Drug delivery. Theoretical calculations for Subconjunctival Drug Administration indicated that local clearance by the blood flow and lymphatics removes most of the Drug dose which is in accordance with experimental results. Calculations suggested that choroidal blood flow removes most of the Drug that has reached the choroid, but this requires experimental verification. Calculations at steady state using the same subconconjunctival input rate showed that the choroidal and vitreal concentrations of the macromolecule is 2-3 orders of magnitude higher than that of small molecules. The evaluation of the roles of the barriers augments to design new Drug delivery strategies for posterior segment of the eye.

Eliisa Mannermaa - One of the best experts on this subject based on the ideXlab platform.

  • Barrier analysis of periocular Drug delivery to the posterior segment.
    Journal of Controlled Release, 2010
    Co-Authors: Veli-pekka Ranta, Eliisa Mannermaa, Kirsi Lummepuro, Astrid Subrizi, Antti Laukkanen, Maxim Antopolsky, Lasse Murtomäki, Margit Hornof, Arto Urtti
    Abstract:

    Periocular Administration is a potential way of delivering Drugs to their targets in posterior eye segment (vitreous, neural retina, retinal pigment epithelium (RPE), choroid). Purpose of this study was to evaluate the role of the barriers in periocular Drug delivery. Permeation of FITC-dextrans and oligonucleotides in the bovine sclera was assessed with and without Pluronic gel in the donor compartment. Computational model for Subconjunctival Drug delivery to the choroid and neural retina/vitreous was built based on clearance concept. Kinetic parameters for small hydrophilic and lipophilic Drug molecules, and a macromolecule were obtained from published ex vivo and in vivo animal experiments. High negative charge field of oligonucleotides slows down their permeation in the sclera. Pluronic does not provide adequate rate control to modify posterior segment Drug delivery. Theoretical calculations for Subconjunctival Drug Administration indicated that local clearance by the blood flow and lymphatics removes most of the Drug dose which is in accordance with experimental results. Calculations suggested that choroidal blood flow removes most of the Drug that has reached the choroid, but this requires experimental verification. Calculations at steady state using the same subconconjunctival input rate showed that the choroidal and vitreal concentrations of the macromolecule is 2-3 orders of magnitude higher than that of small molecules. The evaluation of the roles of the barriers augments to design new Drug delivery strategies for posterior segment of the eye.

Kirsi Lummepuro - One of the best experts on this subject based on the ideXlab platform.

  • Barrier analysis of periocular Drug delivery to the posterior segment.
    Journal of Controlled Release, 2010
    Co-Authors: Veli-pekka Ranta, Eliisa Mannermaa, Kirsi Lummepuro, Astrid Subrizi, Antti Laukkanen, Maxim Antopolsky, Lasse Murtomäki, Margit Hornof, Arto Urtti
    Abstract:

    Periocular Administration is a potential way of delivering Drugs to their targets in posterior eye segment (vitreous, neural retina, retinal pigment epithelium (RPE), choroid). Purpose of this study was to evaluate the role of the barriers in periocular Drug delivery. Permeation of FITC-dextrans and oligonucleotides in the bovine sclera was assessed with and without Pluronic gel in the donor compartment. Computational model for Subconjunctival Drug delivery to the choroid and neural retina/vitreous was built based on clearance concept. Kinetic parameters for small hydrophilic and lipophilic Drug molecules, and a macromolecule were obtained from published ex vivo and in vivo animal experiments. High negative charge field of oligonucleotides slows down their permeation in the sclera. Pluronic does not provide adequate rate control to modify posterior segment Drug delivery. Theoretical calculations for Subconjunctival Drug Administration indicated that local clearance by the blood flow and lymphatics removes most of the Drug dose which is in accordance with experimental results. Calculations suggested that choroidal blood flow removes most of the Drug that has reached the choroid, but this requires experimental verification. Calculations at steady state using the same subconconjunctival input rate showed that the choroidal and vitreal concentrations of the macromolecule is 2-3 orders of magnitude higher than that of small molecules. The evaluation of the roles of the barriers augments to design new Drug delivery strategies for posterior segment of the eye.

Astrid Subrizi - One of the best experts on this subject based on the ideXlab platform.

  • Barrier analysis of periocular Drug delivery to the posterior segment.
    Journal of Controlled Release, 2010
    Co-Authors: Veli-pekka Ranta, Eliisa Mannermaa, Kirsi Lummepuro, Astrid Subrizi, Antti Laukkanen, Maxim Antopolsky, Lasse Murtomäki, Margit Hornof, Arto Urtti
    Abstract:

    Periocular Administration is a potential way of delivering Drugs to their targets in posterior eye segment (vitreous, neural retina, retinal pigment epithelium (RPE), choroid). Purpose of this study was to evaluate the role of the barriers in periocular Drug delivery. Permeation of FITC-dextrans and oligonucleotides in the bovine sclera was assessed with and without Pluronic gel in the donor compartment. Computational model for Subconjunctival Drug delivery to the choroid and neural retina/vitreous was built based on clearance concept. Kinetic parameters for small hydrophilic and lipophilic Drug molecules, and a macromolecule were obtained from published ex vivo and in vivo animal experiments. High negative charge field of oligonucleotides slows down their permeation in the sclera. Pluronic does not provide adequate rate control to modify posterior segment Drug delivery. Theoretical calculations for Subconjunctival Drug Administration indicated that local clearance by the blood flow and lymphatics removes most of the Drug dose which is in accordance with experimental results. Calculations suggested that choroidal blood flow removes most of the Drug that has reached the choroid, but this requires experimental verification. Calculations at steady state using the same subconconjunctival input rate showed that the choroidal and vitreal concentrations of the macromolecule is 2-3 orders of magnitude higher than that of small molecules. The evaluation of the roles of the barriers augments to design new Drug delivery strategies for posterior segment of the eye.